Endometrial Cancer Trial, Recruiting NCT07106359 Sponsor: University of Alabama at Birmingham Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07106359
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For "Probands" (people who have already had genetic testing for Lynch syndrome):

  • People who speak English
  • People who are at least 18 years old
  • People who have previously had genetic testing for Lynch syndrome
  • People who do not have a condition that would affect their ability to give consent and take part in study activities (this is assessed by the trial team during screening)

For "Clinical Trial Participants" (blood relatives of someone diagnosed with Lynch syndrome):

  • People who speak English
  • People who are at least 18 years old
  • People who are a blood relative of someone diagnosed with Lynch syndrome
  • People who may be at risk of having Lynch syndrome themselves
  • People who have not yet scheduled or attended pre-test genetic counselling or genetic testing for Lynch syndrome
  • People who have no personal history of cancer (not counting certain common skin cancers)
  • People who do not have a condition that would affect their ability to give consent and take part in study activities (this is assessed by the trial team during screening)

Who may not be able to join:

  • People who do not speak English
  • People who are under 18 years old
  • People (in the relative group) who have already arranged or completed genetic counselling or testing for Lynch syndrome
  • People (in the relative group) who have a personal history of cancer, other than certain non-melanoma skin cancers
  • People whose ability to give informed consent or complete study activities may be affected by a health condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 205-914-2249

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility (recruitment and retention rates, completeness of assessment data); Use and attitudes towards the education materials; Scheduling and attendance of pre-test genetic counseling and/or genetic testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov